Putting East London at the forefront of healthcare innovations
Right now, opportunities for patients in East London to take part in potentially life-saving clinical trials are limited. But we’re working to change that.
With your support, we will create a new Clinical Research Facility at the Royal London Hospital that will allow more clinical trials to take place in East London. That could mean earlier access to life-changing treatments for local people. It could also mean our diverse communities are better represented in this vital research.
This representation matters – it means new treatments can be more tailored and will be more effective for our local population, as well as making a significant contribution for global research, benefitting millions of underrepresented people around the world.
Suresh recently took part in a clinical trial for rheumatoid arthritis at Whipps Cross Hospital. He’s seen for himself just how life-changing clinical trials can be. Particularly for patients with debilitating conditions.
"By building a state-of-the-art Clinical Research Facility at The Royal London Hospital, more of our diverse local population will be able to take part in drug trials, helping us to make sure these new drugs are safe and effective for everyone.”Professor Rupert Pearse, Professor of Intensive Care Medicine at Queen Mary University of London
A new Clinical Research Facility: our vision
- Our local populations will be better represented in important trials, with the goal of developing tailored and relevant interventions. This will include those living with long-term conditions like diabetes, kidney, heart and liver disease, and rheumatoid arthritis.
- Patients will benefit from the new Facility, since those taking part in clinical trials generally have better experiences and outcomes than those who receive standard care packages. It will also bring greater benefit to the wider population through the earlier translation of research into clinical practice.
- Vastly improved trial facilities with large laboratories and room for patients to stay overnight will enable the hospital to be part of a wider range of studies including early phase trials, novel therapies, remote monitoring, genetics and medical devices.
- The world’s best scientists will be attracted to East London by offering world-class facilities that attract world-class trials. This will bring enhanced reputation and recruitment opportunities for our partners at Barts Health and Queen Mary University of London.
Maximising research opportunities
By creating world-class facilities we will attract world-class trials that will in turn help recruit and retain the world’s best research teams.
These three pillars of excellence will be self-sustaining, since the best research teams will also reinforce the appeal to partners looking for somewhere to conduct their trials.
This model will help transform The Royal London’s Clinical Research Facility from a nationally admired Centre to a globally significant research institution that shapes the future of healthcare through truly world-class innovations.
The project recently received the endorsement of a £1 million National Institute of Health and Care Research (NIHR) Clinical Research Facility infrastructure award, allowing us to join the national NIHR CRF network.